A
Aprea Therapeutics
APRE
3.97000
USD
0.17
(4.47%)
مغلق
حجم التداول
175
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
21,727,612
العنوان: Aprea Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.